← All organizations

PanOptica, Inc.

For profitWebsite ↗

Also known as: PanOptica, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Apr 26, 2018

Timeline

2000s

Jun 1, 2009
PanOptica, Inc.— Founded

Drugs by trial phase (2 distinct, 3 trials)

Phase 2 (1 own, 0 via acquisition)

pan-90806

Phase 1 (1 own, 0 via acquisition)

ranibizumab

Indications

Studied for

Recent trials (5)

NCT03479372Study directorPhase 1/Phase 2Apr 26, 2018
NCT03479372Lead sponsorPhase 1/Phase 2Apr 26, 2018
NCT02475109Lead sponsorPhase 1Aug 1, 2015
NCT02022540Study directorPhase 1Feb 1, 2014
NCT02022540Lead sponsorPhase 1Feb 1, 2014

Details

Founded: Mount Arlington, NJ, US Jun 1, 2009
Last known activity: Apr 26, 2018